- The Weed Blog https://www.theweedblog.com
Share.

GW Pharmaceuticals’ Stock Value Grows After Study Results Revealed

20

epidiolex gw pharmaceuticalsMany in the marijuana world have worried a lot about big pharmaceutical companies taking over the industry. While I think that some of those fears are a bit overblown, I definitely am a little concerned too. I think that big pharmaceutical companies are going to flood the industry, and that there’s not a lot that can be done to stop it. With that being said, I think that there will always be a place in the marijuana industry for small businesses because they have the products that true veteran cannabis consumers really want.

Yesterday was a big day on the marijuana industry front, especially from a pharmaceutical company standpoint, as the results from a study were released by GW Pharmaceuticals. The results were favorable, and the news sent GW Pharmaceuticals’ stock soaring. Per Marijuana Business Daily:

A British maker of cannabis-based drugs revealed some sorely needed good news on Monday, announcing that an epilepsy medicine it created has successfully treated a severe form of epilepsy in children, according to Reuters.

In a clinical study, GW Pharmaceuticals said its Epidiolex syrup reduced the monthly number of seizures in children with Dravet’s Syndrome by 39%, compared to a placebo that reduced the seizures by 13%.

The results of the clinical study propelled the Cambridge-based firm’s stock price to $81.67 in morning trading on the Nasdaq, a gain of more than 112% over Friday’s closing price of $38.46.

On one hand I don’t like seeing pharmaceuticals being brought into the marijuana industry. On the other hand, it’s my understanding that Epidiolex is a 98% oil-based CBD extract, which is different than a lot of products out there that aren’t made form the actual plant. It’s worth noting that while GW Pharmaceuticals’ stock is way up after the results of the study were announced, they are still digging out of a hole that they have themselves in with recent lack luster sales and not-so-favorable results from studies of other products. So before you run out and invest every penny you have, keep that in mind.

Share.

About Author

  • SilentPatriot

    Love to see this. Makes the prohibitionists look like the idiots they truly are. They have a lot of suffering to answer for.

    • Fungi Sclerotia 1427

      No, not idiots, GREEDY!

      This falls right into the plans of the prohibitionists and Big Pharma,
      monetizing extracts of an inexpensively-grown plant
      for inclusion in an exorbitantly-priced prescription medication.

  • Lawrence Goodwin

    The proverbial “devil in the details” appears in the last paragraph of a related report in The New York Times (“Drug Based On Cannabis Meets Goal Of Big Trial,” Tuesday, 3/15/16): Sadly, after all that time and money spent focusing on cannabidiol, many of the families who so desperately need this product will not be able to afford it. “Analysts expect Epidiolex to cost $2,500 to $5,000 a month,…” the Times report says. That equals $30,000 to $60,000 per year for each patient. It seems smarter for parents to just find the right cannabis seeds for their kids’ seizures and start home gardens.

    • saynotohypocrisy

      Analysts expect Epidiolex to cost $2,500 to $5,000 a month,

      What a pile of crap. Turning a cheap safe effective herbal medicine into another exorbitantly priced concoction. Is this concoction supposed to work any better than Colorado produced ‘Charlotte’s Web’?
      Big pharma needs competition from non-profits or the government. Medicine is too important to be controlled by greedballs like this.

      • Lawrence Goodwin

        Epidiolex clearly does work, according to this rigorous study’s results. But another issue was raised by Dr. Sanjay Gupta, in his “Weed” series on CNN, when he pointed to the importance of “the entourage effect”—multiple cannabinoids enhancing each other in medicines that are developed. Hundreds of families can attest to the effectiveness of “Charlotte’s Web,” which the NY Times reported contains “a little” tetrahydrocannabinol. “I don’t need a double-blind placebo-controlled study to know something” works, Colorado mother Allison Ray Benavides was quoted as saying. Her 6-year-old son, Robby, used to endure 15 or 20 seizures per day, but only 5 seizures have occurred since he started ingesting “Charlotte’s Web” oil in 2014. The Times indicated the cost for such products now runs between $100 and $1,000 per month.

        • James Peters

          The entourage effect is yet to be proven in humans. You’d have to show a synergistic effect over isolated compound for all illnesses.

          It’s claimed Charlotte’s Web contains under 0.3% of THC. But if you are basing your claims on anecdotal experience, then any treatment will seem to work for anything and everything so this is why clinical trials are needed.

          • Lawrence Goodwin

            I agree, James. Feel free to call the offices of obstinate Iowa Republican Senator Charles Grassley, chairman of the powerful U.S. Senate Judiciary Committee, to demand he stop single-handedly blocking ALL domestic progress for legitimate scientific research of cannabis plants—specifically, at least ask Grassley what valid reason he has to refuse advancing the proposed CARERS Act out of committee. The research done in Israel by Dr. Raphael Mechoulam’s team, et al. has indicated very strongly that “the entourage effect” is real. Dr. Sanjay Gupta actually used that phrase based on brief interviews in his “Weed” series with Dr. Mechoulam. Did you not see that part?

    • saynotohypocrisy

      It seems smarter for parents to just find the right cannabis seeds for their kids’ seizures and start home gardens.

      You mean other than the possibility that the government will kidnap your kid? Do they do much of that in NY over weed?

      • Lawrence Goodwin

        I was thinking of states, like Maine and Colorado, where it’s legal for parents to grow a few cannabis plants without fear of invasion by the anti-“marihuana” tyranny.

        The New York mothers I had the great privilege of meeting 2 years ago, who traveled from far and wide to urge NY state lawmakers to legalize medical cannabis for their kids, would never take that same grow risk. They execute another strategy. I met truly amazing NY ladies like Missy Miller, Melissa Hilt, Christine Emerson, Wendy Conte (her adorable daughter, Anna, died right when our 2014 law was passed), Maryanne Houser, Margaret Decker (a passionate defender of her niece), and dozens of others. It was mostly these women, led by very savvy Senator Diane Savino (she lost both parents to cancer), who finally forced NY state lawmakers to face the truth about cannabis plants—that they absolutely DO have medical value. I am forever grateful for their ongoing efforts. It breaks so many hearts that NY Gov. Andrew Cuomo has made it virtually impossible—and outrageously expensive—to satisfy the needs of these same women and their families.

        • saynotohypocrisy

          Your last sentence says it all.

  • PhDScientist

    Its worse than people know. Go to uspto.gov and look at all the patents that GWPH has both pending and issued.
    The GWPH guys are good guys. I’ve got nothing against them personally. They’ve put a lot of time and money into this. But I don’t want to see any one company own all the rights to Medical Marijuana and there’s a real danger of that happening, and the financial cost to US patients may go through the roof.

    If you aren’t calling the White House comment line at (202) 446-1111 and emailing the President by going to http://www.whitehouse.gov and clicking on “contact us” and asking that the President get Marijuana removed from Schedule one, and calling and emailing every single day and asking everyone you know to do the same, you should be.

    • Fungi Sclerotia 1427

      Senator Bernard Sanders introduced SB 2237 last fall,
      the “Ending Federal Marijuana Prohibition Act of 2015”
      to remove cannabis from the federal CSA entirely.

      However, this bill has yet to receive support or gain co-sponsors.

      There is a link on NORML’s Take Action page,
      (listed under “Federal” legislation),
      to contact your state’s senators and ask them to support SB 2237.

  • PhDScientist

    We need the President to get Medical Marijuana removed from Schedule 1 NOW, so people can use the “whole plant” rather than having to go to one of the Pharma companies to get single components of it. The entourage effect is real and its significant.

    • saynotohypocrisy

      This seems the same principle as with vitamins, where it’s better to get your vitamins from whole foods than from a pill, for the same reason

    • James Peters

      GW Pharmaceuticals has produced two standardized extract preparations, Tetranabinex, which is high in THC, and Nabidiolex, which is high in CBD. Sativex contains equal proportions of Tetranabinex and Nabidiolex, and, hence, almost equal amounts of THC and CBD. THC and CBD represent approximately 70% of the product, with 5% of other cannabinoids, the remainder being terpenoids, flavonoids, sterols, alkanes, and other chemicals from the plants. I know GW are hoping for the approval of this drug in the US. However the entourage effect has yet to be proven in humans and certain cannabinoids may do nothing for the illness or cause unwanted side-effects like the ”stoned/high” effect from THC

  • PhDScientist

    We Need Change At The Federal Level Now.

  • TheSinnedAngel

    Sorry, but this is not good.

    “Our” companies are being locked out by “our” government but “our” same government is granting U.S. patents to foreign corporations.

    Because it’s illegal at the federal level:
    Our banking system can’t cooperate with us.
    Our IRS can’t work with us.
    But our Patent office can grant patents to foreign corporations?
    .. Why does the “it’s illegal at the federal level” not apply to them?

    Do you realize that the patent office has given them a patent for simple Co2 extraction?

    By the time the feds “let go”, Cannabis and all its derivatives will be “owned” by foreign companies.

    After the Federal Wars end, the Patent Enforcement Wars will begin.
    ..another hundred years lost.

    The Sinned Angel

    • saynotohypocrisy

      Herbal cannabis, the whole plant, needs to be able to compete with big pharma on a level playing field. I suspect cannabis breeders will be able to run rings around big pharma in developing varieties precisely designed to help with specific illnesses, and in getting it to people who need it quickly, and of course at a far reduced price.
      If herbal cannabis can be freely grown and used, including but not limited to prescriptions, covered by insurance, big pharma may not have any role to play, and then their stinking patents wouldn’t matter.
      Big pharma has good reason to be terrified of a level playing field with herbal cannabis.They must be very unhappy with all the studies coming out in the last few years about the effectiveness and safety of cannabis..

    • dagobarbz

      One candle can burn a thousand wheat fields–old saying.

      I swear to god it’s one nation under mammon these days. Our own government is colluding against its own people.

  • Juergen Meixner

    You can’t spell healTHCare without the THC.